To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
OmegavenOmegaven is a fatty acid emulsion produced by Fresenius Kabi. It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome. It is rich in omega-3 fatty acids. Additional recommended knowledgeIt has gained popularity in children in preference to the more commonly used Intralipid after case reports that it reduced the risk of liver damage.[1] A recent study indicated that the use of Omegaven may be an appropriate intervention strategy for newborns with a very low birth weight, gastrochisis, and jejunal atresia.[2] It is currently undergoing a clinical trial at National Taiwan University Hospital.[3] Although the use of Omegaven in children in the United States is experimental, the use of it in adults in Europe is less controversial.[4] In European studies, Omegaven has been associated with a reduction in psoriasis, when contrasted to administration of omega-6 fatty acid Lipoven.[5] Omegaven has also been associated with reduced mortality and antibiotic use during hospital stays.[6] References
Categories: Intensive care medicine | Hepatology | Gastroenterology | Pediatrics | Malnutrition |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Omegaven". A list of authors is available in Wikipedia. |